Medical Science Liaison - Biologics

Medical Science Liaison – Biologics ABOUT ASTRAZENECA AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines for some of the world’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies. SITE DESCRIPTION   AstraZeneca is experiencing a significant transformation in the Kingdom of Saudi Arabia, driven by a commitment to advancing healthcare, innovation, and sustainable growth. Building on our global legacy, AZ KSA is rapidly evolving its operations to better serve patients, collaborate with healthcare stakeholders, and contribute to the ambitious goals outlined in the Saudi Vision 2030. We are investing in talent, digital solutions, and new ways of working; all designed to enhance our impact on patient outcomes and reinforce our leadership in therapeutic areas. This dynamic environment calls for visionary, agile professionals who thrive in change and are motivated to help shape the future of healthcare in KSA.  ROLE SUMMARY   Medical Science Liaison (MSL) possesses extensive scientific expertise in respective therapeutic area and engages in scientific discussions and presentations with KEEs about the disease area, and clinical data in a non-promotional context. This role is accountable for generating actionable insights from KEEs and communicating these to the brand team to shape the Medical and Brand strategy. This role is responsible for a highly strategic product and disease area that involves working extensively with external stakeholders to forge strong relations and foster scientific and strategic partnerships within major hospitals and institutions/ authorities in their assigned territory and non-traditional stakeholders (E.g. policy and decision makers, payer groups, government, researchers, and others to help bridge the gaps and provide health system solutions.   What you’ll do Build, enhance, maintain advocacy of Key External Experts (KEEs) • Identify, prioritize, and expand KEEs to include non-traditional stakeholders (E.g. policy and decision makers, payer groups, government, researchers, and others) based on scientific/clinical expertise and practice change influence within a specific hospital and institution/ authorities, and engage in robust scientific discussions and medical advancements in a balanced, objective, and accurate way. • Identify, and prioritize accounts based on patient care pathway and map the multidisciplinary team and maturity. • Provide AZ with an understanding of the local medical community, clinical practice trends, HCP insight and real or perceived gaps in current scientific knowledge, patient journey, and disease management. • Foster scientific partnerships with KEEs to help advance disease understanding and to achieve evidence-based changes in medical practice that are consistent with Medical Affairs strategy & objectives, such as:                              i.     Interact in the field with the medical community in the context of various medical projects such as clinical trials, Non-Interventional Studies, Investigator Sponsored Studies (ISSs), scientific exchange.                             ii.      Identify potential speakers and train speakers as appropriate for local events.                            iii.     Provide recommendations for advisory board / round table discussion participants and serve as faculty/facilitators for advisory board meetings.                            iv.     Present scientific data to HCPs in both group (Medically led meetings) and one on one setting.                             v.     Facilitate continuing medical education events for HCPs.                            vi.     Suppo